1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015 Global Survey on Liquid Biopsy Adoption Trends

2015 Global Survey on Liquid Biopsy Adoption Trends

  • November 2015
  • -
  • Frost & Sullivan
  • -
  • 86 pages

Summary

Table of Contents

Learn the Promising Technologies and Bottlenecks for CTCs and ctDNA—A Voice of Customer Study

The primary goal of this research is to analyze the current and future adoption patterns on the usage of liquid biopsy. Key information the survey seeks to collect include the following:
- Current and future use of liquid biopsy by organization type
- Timeframe of liquid biopsy adoption amidst future users
- Predominantly used cell types—CTCs, ctDNA, cfDNA and Evs—by organization type
- Sample inflow to conduct liquid biopsy tests
- Preference for sample types: blood, saliva, stool, serum, and so on.
- Correlation analysis of sample type and biomarker type
- Promising applications for liquid biopsy—current and future
- Predominant approaches to liquid biopsy: hotspot panels, single marker tests, and so on
- Technologies used to detect CtDNA—current vs. future users
- Technologies used to detect CTCs
- Vendor popularity for specific biomarkers and reimbursement scenario
- Bottlenecks to mainstream implementation of liquid biopsy

Research Objectives
The primary goal of this research is to analyze the current and future adoption patterns on the usage of liquid biopsy. Key information the survey seeks to collect include the following:
- Current and future use of liquid biopsy by organization type
- Timeframe of liquid biopsy adoption amidst future users
- Predominantly used cell types—CTCs, ctDNA, cfDNA and EVs—by organization type
- Sample inflow to conduct liquid biopsy tests
- Preference for sample types: blood, saliva, stool, serum, and so on.
- Correlation analysis of sample type and biomarker type
- Promising applications for liquid biopsy—current and future
- Predominant approaches to liquid biopsy: hotspot panels, single marker tests, and so on
- Technologies used to detect ctDNA—current vs. future users
- Technologies used to detect CTCs
- Vendor popularity for specific biomarkers and reimbursement scenario
- Bottleneck to mainstream implementation of liquid biopsy

Research Methodology

Methodology
Clinical and Research Laboratories were invited to participate in an online survey in July 2015. To qualify for survey participation, respondents must work within a private or public laboratory, academic research facility, hospital lab or a pharmaceutical or diagnostic company that employs liquid biopsy technologies. Respondents should be a constant user of liquid biopsy technologies, belong to the scientific community, and be in a position to authorize purchases and handle laboratory budgets.

Sample
The target group was screened to ensure only qualified respondents participated. In total, decision makers qualified for the survey, representing the following types of laboratories:

Pharmaceutical and diagnostic companies
Research institutes and universities
Hospital laboratories
Reference laboratories (includes CLIA-/CAP-certified laboratories)

Reporting Notes
- Respondents indicated a wide range of job titles, such as lab directors, scientists, lab managers, oncologists, clinicians, pathologists, and lab technicians.
- In total, about % of respondents work in the United States, and about % work in Europe. Nevertheless, this study is considered global because the survey was open to respondents from all countries.
- Due to rounding, percentages in charts and tables may not sum to .

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Biopsy Device Market: Needles Product Type Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026

Biopsy Device Market: Needles Product Type Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026

  • $ 5000
  • Industry report
  • January 2017
  • by Future Market Insight Global & Consulting Pvt Ltd

Government initiatives in cancer treatment to fuel growth of the global biopsy device market during the projected period Global demand for biopsy devices is increasing, supported by rising incidence of ...

Canada Biopsy Devices Market Outlook to 2023

Canada Biopsy Devices Market Outlook to 2023

  • $ 4995
  • Industry report
  • March 2017
  • by GlobalData

Canada Biopsy Devices Market Outlook to 2023 Summary GlobalData’s new report, "Canada Biopsy Devices Market Outlook to 2023", provides key market data on the Canada Biopsy Devices market. The report ...

Brazil Biopsy Devices Market Outlook to 2023

Brazil Biopsy Devices Market Outlook to 2023

  • $ 4995
  • Industry report
  • March 2017
  • by GlobalData

Brazil Biopsy Devices Market Outlook to 2023 Summary GlobalData’s new report, "Brazil Biopsy Devices Market Outlook to 2023", provides key market data on the Brazil Biopsy Devices market. The report ...


Download Unlimited Documents from Trusted Public Sources

Diagnostics Forecast in the US

  • March 2017
    2 pages
  • United States  

View report >

Diagnostics Forecast in the US

  • February 2017
    2 pages
  • Diagnostics  

    Cancer  

    Health Care Pro...  

  • United States  

View report >

The future of the Clinical Trial Industry in the US

  • January 2017
    2 pages
  • Clinical Trial  

    Genome Sequenci...  

    Biopsy  

  • United States  

View report >

Related Market Segments :

Biopsy

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.